FGFR3 mutations as classifier of tumor progression and specific survival in T1G3 urothelial cell carcinoma of the bladder

被引：0
|
作者：
Bakkar, A
Wallerand, H
Vordos, D
Salomon, L
Saint, F
Swieb, S
Abbou, CC
de Medina, SGD
Chopin, DK
机构：
来源：
JOURNAL OF UROLOGY | 2005年 / 173卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)35073-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
917
引用
收藏
页码：248 / 248
页数：1
相关论文
共 50 条
  • [1] T1G3 transitional cell carcinoma of the bladder: recurrence, progression and survival
    Peyromaure, M
    Zerbib, M
    BJU INTERNATIONAL, 2004, 93 (01) : 60 - 63
  • [2] No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer
    Otto, Wolfgang
    Denzinger, Stefan
    Bertz, Simone
    Gaumann, Andreas
    Wild, Peter J.
    Hartmann, Arndt
    Stoehr, Robert
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (09) : 2205 - 2208
  • [3] Establishing the prediction models for recurrence and progression of T1G3 bladder urothelial carcinoma
    Chen, Song
    Lu, Mengxin
    Peng, Tianchen
    Wang, Yejinpeng
    Liu, Xuefeng
    Xiao, Yu
    Wang, Xinghuan
    JOURNAL OF CANCER, 2019, 10 (24): : 5891 - 5902
  • [4] Validation of the CUETO scoring model for predicting recurrence and progression in T1G3 urothelial carcinoma of the bladder
    Krajewski, W.
    Rodriguez-Faba, O.
    Breda, A.
    Pisano, F.
    Poletajew, S.
    Tukiendorf, A.
    Zdrojowy, R.
    Kolodziej, A.
    Patou, J.
    ACTAS UROLOGICAS ESPANOLAS, 2019, 43 (08): : 445 - 451
  • [5] Tumour progression and survival in patients with T1G3 bladder tumours
    Somogyi, L
    BRITISH JOURNAL OF UROLOGY, 1998, 82 (04): : 608 - 609
  • [6] FGFR3 and Tp53 mutations in T1G3 transitional bladder carcinomas:: Independent distribution and lack of association with prognosis
    Hernández, S
    López-Knowles, E
    Lloreta, J
    Kogevinas, M
    Jaramillo, R
    Amorós, A
    Tardón, A
    García-Closas, R
    Serra, C
    Carrato, A
    Malats, N
    Real, FX
    CLINICAL CANCER RESEARCH, 2005, 11 (15) : 5444 - 5450
  • [7] Mutations of TERT promoter and FGFR3 in urothelial carcinoma of urinary bladder in Korean patients
    Choi, C.
    Kim, S-S.
    Byeun, J-Y.
    VIRCHOWS ARCHIV, 2017, 471 : S279 - S279
  • [8] FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
    Guancial, Elizabeth A.
    Werner, Lillian
    Bellmunt, Joaquim
    Bamias, Aristotle
    Choueiri, Toni K.
    Ross, Robert
    Schutz, Fabio A.
    Park, Rachel S.
    O'Brien, Robert J.
    Hirsch, Michelle S.
    Barletta, Justine A.
    Berman, David M.
    Lis, Rosina
    Loda, Massimo
    Stack, Edward C.
    Garraway, Levi A.
    Riester, Markus
    Michor, Franziska
    Kantoff, Philip W.
    Rosenberg, Jonathan E.
    CANCER MEDICINE, 2014, 3 (04): : 835 - 844
  • [9] Pattern of recurrence and progression according to substaging and with or without BCG treatment in T1G3 urothelial bladder carcinoma
    Palou, J
    Rodriguez, O
    Vayreda, JM
    Huguet, J
    Gómez, J
    Algaba, F
    Villavicencio, H
    JOURNAL OF UROLOGY, 2006, 175 (04): : 272 - 273
  • [10] Tumour progression and survival in patients with T1G3 bladder tumours - Reply
    Herr, HW
    BRITISH JOURNAL OF UROLOGY, 1998, 82 (04): : 609 - 609
12345